|Day Low/High||1.50 / 1.56|
|52 Wk Low/High||1.45 / 3.70|
Company provides 2017 highlights and 2018 development program guidance
Specific therapeutic use claim in oral mucositis adds to existing composition of matter claims
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.